These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10829262)

  • 1. Antibacterial agents in infections of the central nervous system.
    Chowdhury MH; Tunkel AR
    Infect Dis Clin North Am; 2000 Jun; 14(2):391-408, ix. PubMed ID: 10829262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies and new developments in the management of bacterial meningitis.
    Miranda J; Tunkel AR
    Infect Dis Clin North Am; 2009 Dec; 23(4):925-43, viii-ix. PubMed ID: 19909891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial agents in infections of the central nervous system and eye.
    Papastamelos AG; Tunkel AR
    Infect Dis Clin North Am; 1995 Sep; 9(3):615-37. PubMed ID: 7490436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations.
    Schmidt T; Täuber MG
    J Antimicrob Chemother; 1993 May; 31 Suppl D():61-70. PubMed ID: 8335525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies for central nervous system infections: an update.
    Tan YC; Gill AK; Kim KS
    Expert Opin Pharmacother; 2015 Feb; 16(2):187-203. PubMed ID: 25328149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial meningitis: pathophysiology and therapy 1991].
    Schaad UB
    Schweiz Med Wochenschr; 1991 Aug; 121(34):1217-22. PubMed ID: 1925451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacterial infections of the central nervous system].
    Klein M; Pfister HW
    Nervenarzt; 2010 Feb; 81(2):150-61. PubMed ID: 20084360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
    Skogen PG; Kolmannskog S; Bergh K
    Clin Microbiol Infect; 2001 Jan; 7(1):39-42. PubMed ID: 11284946
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial agents in the treatment of bacterial meningitis.
    Sinner SW; Tunkel AR
    Infect Dis Clin North Am; 2004 Sep; 18(3):581-602, ix. PubMed ID: 15308277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial meningitis - principles of antimicrobial treatment.
    Jawień M; Garlicki AM
    Przegl Epidemiol; 2013; 67(3):421-7, 529-33. PubMed ID: 24340554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.
    Jiménez-Mejías ME; Pichardo-Guerrero C; Márquez-Rivas FJ; Martín-Lozano D; Prados T; Pachón J
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):212-4. PubMed ID: 11957024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated approach to healthcare-associated meningitis.
    Bardak-Ozcem S; Sipahi OR
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):333-42. PubMed ID: 24512210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
    Hachem R; Afif C; Gokaslan Z; Raad I
    Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of dosing schedules and cerebrospinal fluid bactericidal activity on the therapy of bacterial meningitis.
    Scheld WM; Tauber MG; Zak O; Sande MA
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():303-12. PubMed ID: 3980333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid.
    Lebel MH
    Antibiot Chemother (1971); 1992; 45():226-38. PubMed ID: 1610135
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?
    Kumta N; Roberts JA; Lipman J; Cotta MO
    Clin Pharmacokinet; 2018 Apr; 57(4):439-454. PubMed ID: 28905331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated gonococcal infection and meningitis.
    Mofredj A; Baraka D; Madec Y; Lemaitre P
    Am J Med; 2000 Jul; 109(1):71-2. PubMed ID: 10991742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.